Genotype-guided Anticoagulation
Genotype-Guided Anticoagulation is a pharmacogenomic strategy that integrates individual genetic variation, particularly in genes such as CYP2C9 and VKORC1, to optimize the dosing and selection of anticoagulant therapy, thereby improving therapeutic efficacy and minimizing adverse drug reactions.
122
Publications
9.5K
Citations
781
Authors
286
Institutions
Publications per year
2017–2026
28
122
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson et al. · New England Journal of Medicine · 2013 · 808 citations · Full text
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 522 citations · Full text
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
Mia Wadelius, L Y Chen, Kate Downes et al. · The Pharmacogenomics Journal · 2005 · 467 citations
1–5 of 122
781
9
h-index
6
h-index
5
h-index
5
h-index
4
h-index
1–5 of 781
286

Washington University in St. Louis
St Louis, United States
9 h-index
39 publications
8.7K citations
University of Florida
Gainesville, United States
6 h-index
11 publications
2.4K citations

Uppsala University
Uppsala, Sweden
6 h-index
14 publications
5.6K citations

University of Liverpool
Liverpool, United Kingdom
5 h-index
19 publications
6.8K citations
University of Utah
Salt Lake City, United States
5 h-index
16 publications
2.4K citations
Chinese University of Hong Kong
Hong Kong, Hong Kong
5 h-index
12 publications
722 citations
Marshfield Clinic
Marshfield, United States
4 h-index
23 publications
6.2K citations
University of Pennsylvania
Philadelphia, United States
4 h-index
11 publications
1.7K citations
1–8 of 286
CPT · 10 publications · 1.8K citations
10
h-index
7 publications · 377 citations
7
h-index
6 publications · 322 citations
6
h-index
6 publications · 348 citations
6
h-index
Repository · 6 publications · 86 citations
6
h-index
1–5